The independent source for health policy research, polling, and news.
6,761-6,780 of 112,963 results
If a Senate appropriations proposal is approved, Secretary of State Antony Blinken would have 90 days to draft a report that would reveal, for the first time, key data on overdoses from fake pills sourced in Mexico. Also in the news: drug overdoses in schools; fentanyl deaths in Kansas City; more.
A USDA report finds that only 6.2 million of the eligible 12.1 million people received benefits from the Special Supplemental Nutrition Program for Women, Infants, and Children in 2021. The SNAP program is separately in the news as the new House speaker has been part of the push to overhaul the anti-hunger program.
A CDC report released Thursday said 10% of high school students said they had used electronic cigarettes in the past month, down from 14% last year. The report also noted that about 90% of students who vaped said they used flavored products. Among middle school students, the rate of tobacco users increased from 4.5% to 6.6%.
The final regulation is in line with proposed payment cuts that were published over the summer. Many doctors can expect to see a decrease in their reimbursements, unless Congress steps in. CMS also released another Medicare rule that moves forward with a plan to claw back funds from some hospitals to compensate for 340B overpayments.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Editorial writers examine birth control, obesity drugs, CRISPR and more.
The overdoses among students at a high school in Sterling, Virginia, show how dramatic the opioid crisis has become — all of them required medical intervention of some sort. Meanwhile, the Supreme Court has been asked for the first time to block anti-trans youth care laws in Tennessee.
The lawsuit was filed last week after the death of a 21-year-old who suffered a heart condition. In other news, a new study linked race factors to depression among college students who are minorities at both predominantly white and Black institutions.
The survey from the Annenberg Public Policy Center of the University of Pennsylvania also shows the percentage of Americans who believe approved vaccines are are safe dropped 6 points since April 2021 to 71%. Separately, Moderna posted a quarterly loss, thanks to impacts from unused covid shots.
Most stores remained open during the three-day walkout action among some pharmacists, the companies said. In other pharma news, Nostrum Laboratories will pay up to $50 million to settle allegations of underpaid Medicaid rebates; Apple's long-term plans to revolutionize health care; and more.
Now that it's time to pick health coverage for 2024 on the ACA's marketplaces, experts are reminding buyers to research which plans they're choosing to avoid expensive surprises.
The complex case unfolded amid Idaho's strict anti-abortion laws, which include a ban on helping minors without their parents' consent, and centers around a young girl who was living with her boyfriend's family and then taken out of state to get an abortion.
People ages 50 to 80 who smoke now or used to smoke and have at least a "20 pack-year" history of smoking should get an annual low-dose CT scan, the group says. A "pack-year" is defined as equal to smoking one pack of cigarettes per day for a year.
Today's early morning highlights from the major news organizations.
Read recent commentaries about pharmaceutical issues.
Editorial writers tackle climate change, social media, medical-assisted suicide and more.
Read recent pharmaceutical developments in KFF Health News' Prescription Drug Watch roundup.
Under the law, private companies that punish workers for refusing a covid shot could get a $50,000 fine. Meanwhile, Houston Independent School District nurses are voicing their anger at a plan to have them staff two covid clinics without extra pay. Other news is from California, Florida, Long Island, and elsewhere.
Only 36% of physicians surveyed by Medscape said they weren't "very" or "at all" concerned about the influence of AI on diagnoses and treatment decisions. In other news, Eli Lilly is buying gene-editing tech from Beam Therapeutics; strong sales of RSV vaccines lift GSK's profits; and more.
© 2026 KFF